Pimecrolimus Repairs Steroid-Induced Skin Damage in AD

Intermittent treatment with pimecrolimus over 1 year significantly reverses corticosteroid-induced skin atrophy and telangiectasia, a phase 4 study reports. Medscape News UK

Read the full article on medscape.com